Percutaneous Suture Systems Market
The market for Percutaneous Suture Systems was estimated at $1.1 billion in 2024; it is anticipated to increase to $2.1 billion by 2030, with projections indicating growth to around $3.6 billion by 2035.
Global Percutaneous Suture Systems Market Outlook
Revenue, 2024
Forecast, 2034
CAGR, 2025 - 2034
The Percutaneous Suture Systems industry revenue is expected to be around $1.2 billion in 2025 and expected to showcase growth with 11.8% CAGR between 2025 and 2034. Building on this growth trajectory, percutaneous suture systems are gaining strong clinical relevance as minimally invasive procedures become the standard of care across multiple specialties. Their importance is closely tied to the rising preference for reduced surgical trauma, shorter hospital stays, and faster patient recovery. Increasing volumes of cardiovascular and orthopedic interventions, along with the expansion of ambulatory surgical centers, are reinforcing demand. Additionally, advancements in catheter-based techniques and physician familiarity with image-guided procedures are supporting broader adoption. The growing emphasis on cost efficiency in healthcare systems further enhances their role, as these systems help reduce complication rates and overall procedural costs.
Percutaneous suture systems are specialized medical devices designed to deliver sutures through small skin punctures, enabling closure of vascular access sites or soft tissue without the need for open surgery. These systems typically consist of needle-based or catheter-assisted mechanisms that allow precise suture placement under imaging guidance. They are widely used in applications such as vascular closure following catheterization procedures, cardiac interventions, and minimally invasive orthopedic repairs. Key features include reduced invasiveness, improved hemostasis, and enhanced procedural efficiency. Recent trends driving demand include the rise of transcatheter therapies, increasing adoption in outpatient settings, and continuous innovation in device design to improve ease of use and patient outcomes.
Market Key Insights
The Percutaneous Suture Systems market is projected to grow from $1.1 billion in 2024 to $3.3 billion in 2034. This represents a CAGR of 11.8%, reflecting rising demand across Cardiovascular Surgeries, Gastrointestinal Procedures, and Orthopedic Surgeries.
Johnson & Johnson, Medtronic PLC, and B. Braun Melsungen AG are among the leading players in this market, shaping its competitive landscape.
U.S. and Germany are the top markets within the Percutaneous Suture Systems market and are expected to observe the growth CAGR of 8.6% to 12.4% between 2024 and 2030.
Emerging markets including Brazil, India and South Africa are expected to observe highest growth with CAGR ranging between 11.3% to 14.8%.
Transition like Shift from traditional vascular closure methods to suture-mediated percutaneous solutions is expected to add $245 million to the Percutaneous Suture Systems market growth by 2030.
The Percutaneous Suture Systems market is set to add $2.2 billion between 2024 and 2034, with manufacturer targeting Clinics & Ambulatory Surgical Centers Application projected to gain a larger market share.
With Rising demand in minimally invasive surgeries, and technological Innovations for Improved Wound Healing, Percutaneous Suture Systems market to expand 205% between 2024 and 2034.